Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
InspireMD ( (NSPR) ) just unveiled an announcement.
On February 27, 2026, InspireMD, Inc. issued a dismissal notice to Chief Operating Officer Andrea Tommasoli, who has been employed under a French law-governed contract with its subsidiary since November 2, 2020. His employment termination is subject to a six-month notice period and applicable French labor laws, reflecting the company’s need to manage executive changes within a tightly regulated European employment framework.
Tommasoli was released from his operational duties effective April 1, 2026, but will continue to receive base salary through the end of the notice period, along with health and provident benefits for up to 12 months under French law. He is also entitled to approximately €61,000 in severance and payment for accrued, unused leave, with his final working day expected on September 1, 2026, signaling a planned leadership transition that may influence the company’s operational oversight in Europe.
The most recent analyst rating on (NSPR) stock is a Buy with a $5.00 price target. To see the full list of analyst forecasts on InspireMD stock, see the NSPR Stock Forecast page.
Spark’s Take on NSPR Stock
According to Spark, TipRanks’ AI Analyst, NSPR is a Neutral.
NSPR’s score is held back primarily by very weak financial performance (massive losses and heavy cash burn) and bearish technicals (trading below major moving averages with negative MACD). Offsetting factors include encouraging earnings-call fundamentals—strong Q3 growth, improved gross margin, and constructive Q4 revenue guidance—plus a low-debt balance sheet, but profitability and cash flow remain the key risks.
To see Spark’s full report on NSPR stock, click here.
More about InspireMD
InspireMD, Inc. is a medical device company operating through its subsidiary InspireMD Ltd. The company focuses on vascular intervention technologies, including specialized products for treating cardiovascular conditions, and serves healthcare providers in international markets subject to varying labor and regulatory regimes.
Average Trading Volume: 37,400
Technical Sentiment Signal: Sell
Current Market Cap: $72.03M
For a thorough assessment of NSPR stock, go to TipRanks’ Stock Analysis page.